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Abstract 
Traditional basal-bolus and closed-loop artificial pancreas therapy for type 1 diabetes mellitus 
were studied in the present work and novel insulin delivery profiles have been identified.  
         Type 1 diabetes is a chronic condition resulting from autoimmune destruction of the 
pancreatic insulin producing β-cells. Inadequate insulin secretion prevents efficient glucose 
metabolism and is a serious health risk. Major available treatment modes are multiple daily 
injections of insulin and insulin pump therapy providing continuous subcutaneous infusion. 
General insulin regimens for low- and high-fat meals were studied in silico to improve current 
pump therapy for type 1 diabetes. This involved modifications of the FDA-accepted 
UVA/Padova metabolic simulation model for evaluations of meals with different absorption 
rates. Simulations of meals with varied fat content under this modified model demonstrated 
qualitative replications of published data. Subsequently, an insulin regimen library with 
optimized regimens under open- and closed-loop settings for a variety of meal compositions was 
constructed using the particle swarm optimization algorithm. 
         Calculations show that the optimal open-loop insulin delivery profiles for low-fat meals 
comprise a normal bolus or short square wave depending on the size of the meal. The preferred 
delivery pattern for large meals is a short insulin wave due to the increased risk for 
hypoglycemia. Interestingly, the optimal open-loop regimens for high-fat meals are typically 
biphasic, but can extend to multiple phases for large slow absorbing meals. Furthermore, 
individual in silico optimizations revealed that patients with high insulin sensitivity could benefit 
from biphasic insulin deliveries when consuming high-fat meals. Preliminary investigations of 
the optimal closed-loop regimens under varied fat content also display bi- or triphasic patterns 
for high-fat meals and are primarily influenced by the carbohydrate content in the meal.  
         The novel insulin delivery profiles identified in this work comprise new and unique 
waveforms that provide better control of postprandial glucose excursions than existing schemes.  
Furthermore, the novel regimens are also more or similarly robust to uncertainties in various 
parameter estimates with the closed-loop schemes displaying superior performance and 
robustness. The proposed closed-loop strategy does not rely on optimal basal therapy and is 
therefore a realistic approach that could have real-life applications in an artificial pancreas.  
Keywords: type 1 diabetes, insulin pump therapy, insulin dosage, artificial pancreas,  
                    particle swarm optimization, biomedical control 
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1. Introduction 
Diabetes mellitus is a chronic condition caused either by the inability of the pancreas to produce 
enough insulin or insufficient insulin secretion accompanied by the body’s resistance to the 
effects of insulin (Daneman, 2006). The former is known as type 1 diabetes mellitus and is the 
focus of this thesis work. Without adequate insulin secretion, the body is unable to metabolize 
blood glucose and use it as an efficient energy source. Since glucose is one of the main energy 
sources for most cells in the body, a stable glucose concentration is essential to avoid serious 
complications (Stemmann, 2013). Hence, people with diabetes require insulin therapy to 
maintain normal blood glucose concentrations.  
         Rapid increases in blood glucose concentration resulting from meals are difficult to control 
in people with diabetes mellitus due to the lack of endogenous insulin production. As a result, 
meal compensation is one of the main challenges associated with blood glucose control. Type 1 
diabetes mellitus is most commonly treated with subcutaneous insulin injections (Farmer et al., 
2008). This is a type of open-loop insulin delivery that requires user “announcements” of meals 
and exercise events. A more developed form of this open-loop method is insulin pump therapy, 
which is a continuous insulin infusion system that delivers insulin subcutaneously. It provides 
basal insulin continuously throughout the day and delivers additional boluses around mealtimes 
based on user inputs. Automated closed-loop insulin delivery, also referred to as the artificial 
pancreas (AP), is an emerging treatment approach for type 1 diabetes mellitus that will ideally 
eliminate patient involvement in determining insulin boluses prior to meals and exercise. Several 
control algorithms for this approach have been proposed, the main algorithms being model 
predictive control (MPC) (Dassau et al., 2013), proportional-integral-derivative (PID) control 
(Kumareswaran et al., 2012), and fuzzy logic control (Liu et al., 2013).  
         This thesis aims at finding optimal insulin regimens for a variety of meal compositions 
using the Particle Swarm Optimization method (Kennedy et al., 1995). This is done in both an 
open-loop and a closed-loop setting with user announcements through in silico trials on ten adult 
subjects. The main purpose of this research is to improve open- and closed-loop insulin therapy 
by creating an insulin regimen optimizer that can be used to construct an insulin regimen library 
with a set of optimal bolus recommendations for various meal types of different sizes.  
         The thesis work was conducted in the research group of Professor Francis J. Doyle III at 
the Department of Chemical Engineering, University of California, Santa Barbara in cooperation 
with the Sansum Diabetes Research Institute.  
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1.1 Problem Statement 
With conventional basal-bolus (open-loop) delivery techniques, the patient must either determine 
the insulin dose to be administered or provide information about an upcoming meal or exercise. 
The main challenge in open-loop basal-bolus meal compensation lies in choosing the appropriate 
insulin regimen because the postprandial blood glucose profile varies with meal composition. 
Since the meal absorption rate is dependent on meal composition, the insulin regimen needs to be 
altered between different meal types to obtain optimal blood glucose control. Choosing the 
wrong insulin regimen can result in postprandial hyper- or hypoglycemia, which can cause 
serious health problems such as ketoacidosis, cardiovascular disease, kidney failure, and 
blindness (WHO, 2013).  
          Insulin pump therapy is a commonly used open-loop method that requires the patient to 
estimate the meal or exercise load, after which the device determines the change in insulin 
infusion that is necessary to maintain near-euglycemia (Farmer et al., 2008). The traditional 
insulin pump offers only a limited number of bolus options, and to the author’s knowledge, other 
insulin regimens have not yet been explored.  
 
 
1.2 Objective  
This thesis aims at finding the optimal insulin regimens in both open- and closed-loop settings 
for various meal types through in silico trials. It has been consistently shown that the choice of 
insulin regimen is crucial for good postprandial blood glucose control and is the motivation for 
this thesis work. The aim is to improve open- and closed-loop insulin therapy by developing an 
insulin regimen optimizer that can be used in silico for a range of different meals. With the given 
optimizer it will be possible to construct an insulin regimen library with a set of optimal bolus 
recommendations for various meal types of different sizes under both open- and closed-loop 
insulin therapies based on each subject’s individual clinical parameters.  
 
 
1.3 Thesis Outline 
The first chapter of this thesis provides an introduction to diabetes mellitus, defines the problem, 
and describes the objectives of this work. The following chapter provides additional background 
information on type 1 diabetes mellitus, blood glucose homeostasis, available treatment options 
and insulin regimens as well as the artificial pancreas. Subsequently, the preparatory work and 
analysis for enabling simulation of slow absorbing meals is presented. This is followed by an 
introduction to the concept of open- and closed-loop insulin regimen optimization as well as a 
presentation of the results for three different meal types. The results from the robustness analysis 
are presented next, providing a comparison with existing schemes. The final chapter presents a 
conclusion of the results obtained in this study and offers some suggestions for future work.  
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2. Background 
Diabetes mellitus is classified into two main types: type 1 and type 2. Type 2 diabetes is caused 
by insufficient insulin secretion accompanied by insulin resistance and is the most common form 
of diabetes, affecting 90% of people with diabetes around the world. Conversely, type 1 diabetes 
is a condition characterized by the destruction of pancreatic β-cells and currently affects 10% of 
people with diabetes (WHO, 2013). All types of diabetes mellitus lead to chronically elevated 
blood glucose concentrations. This is dangerous since experiencing high blood glucose 
concentrations over long periods of time can lead to serious health problems such as 
ketoacidosis, a life-threatening condition (Williamson, 2011). 
         Diabetes currently affects more than 371 million people worldwide and approximately 50% 
remain undiagnosed (IDF, 2013). Most people with diabetes are between 40 to 59 years of age. 
However, the number of young people suffering from diabetes is increasing, with 78 000 
children developing type 1 diabetes each year (IDF, 2012). Diabetes is currently one of the 
leading causes of blindness and kidney failure and is predicted to become the seventh leading 
cause of death in the world by 2030 (WHO, 2013).  
 
 
2.1 Type 1 Diabetes Mellitus 
Type 1 diabetes mellitus is a chronic condition that causes selective destruction of insulin 
producing pancreatic β-cells. Since these are the only cells that produce insulin in the body, this 
destruction causes a loss of endogenous insulin production, leading to absolute insulin 
deficiency. Type 1 diabetes mellitus can be further classified into type 1A and type 1B diabetes, 
of which the first kind results from a cell-mediated autoimmune attack on the β-cells. The 
mechanism for the β-cell destruction in type 1B diabetes is currently unknown, but possibly 
involves certain genetic markers (Daneman, 2006). Without adequate insulin secretion, the body 
is unable to metabolize blood glucose and use it as an efficient energy source. The body cells  are 
thus forced to use fatty acids for fuels, causing a toxic buildup of keto acids in the body over 
time (Williamson, 2011).  
          Studies suggest that the development of type 1 diabetes depends on both environmental 
factors as well as a genetic predisposition to the disease (Daneman, 2006). It can develop at any 
age, but typically occurs in childhood or adolescence with both genders being at equal risk. 
Some of the risk factors for developing type 1 diabetes include: having a parent with type 1 
diabetes, having other autoimmune disorders, and being ill in early infancy (Univ. of Maryland, 
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2013). Common symptoms associated with the disease are great thirst, hunger, weight loss, and a 
need to urinate often (Rubin, 2008).  
         Without treatment, people with type 1 diabetes experience persistently elevated blood 
glucose concentrations, which can lead to serious damage to the body, particularly to the nerves 
and blood vessels (Rubin, 2008). There are numerous health risks associated with diabetes, such 
as blindness, kidney failure, and extensive nerve damage (Daneman, 2006). Although there is no 
known cure for diabetes, the aim of diabetes treatment is to avoid such serious complications or 
at least slow down their development. 
 
 
2.2 Blood Glucose Homeostasis 
Glucose is a monosaccharide that the body receives through dietary sources or is produced 
primarily from carbohydrates, but also from protein and fat. It is one of the main energy sources 
for most cells in the body. Upon meal ingestion, glucose is transported from the intestine and 
absorbed directly into the blood. It is then carried through the bloodstream to provide energy to 
various cells in the body. (McMillin, 1990) 
          Glucose homeostasis is a regulatory process involving multiple pancreatic hormones: 
insulin, glucagon, amylin, incretin hormones, epinephrine, cortisol, and growth hormone 
(Aronoff et al., 2004). People that do not suffer from type 1 diabetes have a fully functioning 
glucose regulatory system that is driven mainly by the hormone, insulin. Fig. 1 provides a 
simplified illustration of the regulatory system in a healthy individual.  
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Figure 1. Blood glucose regulatory system (adapted from Marieb, 2000). 
 
          As shown in Fig. 1, insulin stimulates the rate of glucose disappearance by activating 
glycogen formation and glucose uptake by muscle and tissue cells. It essentially regulates the use 
and storage of glucose in the body, which helps maintain normal blood glucose concentrations 
and avoid hyperglycemia, i.e. elevated blood glucose levels (Shrayyef et al., 2010). Amylin is 
another glucoregulatory hormone that is co-secreted by the β-cells along with insulin to prevent 
postprandial spikes in blood glucose concentration. It slows down digestion and the rate of 
glucose entering the bloodstream (Aronoff et al., 2004). Counterregulatory hormones to insulin 
such as glucagon, cortisol, catecholamines, and growth hormone are released to avoid 
hypoglycemia, i.e. low blood glucose levels (Shrayyef et al., 2010).  
         Elevated blood glucose concentrations activate the glucagon-like peptide-1 (GLP-1) 
receptors on the β-cells. The binding of this pancreatic incretin hormone to its receptor stimulates 
insulin and amylin secretion and inhibits glucagon secretion by the pancreas as shown in Fig. 1. 
Postprandial insulin release involves an initial rapid secretion of preformed insulin followed by 
increased insulin production and release depending on the blood glucose concentration. Insulin 
secretion induces an increased glucose uptake in the cells of muscle and adipose tissue, promotes 
glycogenesis, and prevents glucagon secretion from the pancreatic α-cells. This signals the liver 
to stop glucose production by glycogenolysis and gluconeogenesis (Aronoff et al., 2004). 
Conversely, glucagon and epinephrine secretion are stimulated by low blood glucose 
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concentrations, i.e. below 65-70 mg/dl. The release of glucagon promotes the conversion of 
stored glycogen into glucose by binding to its receptors in the liver, while epinephrine promotes 
glucose production in the kidneys (Stemmann, 2013). 
          Inadequate insulin secretion limits the cells from accessing glucose for energy, resulting in 
hyperglycemia. It causes glucose to accumulate in the blood, which forces the cells to use fatty 
acids for fuel. However, fatty acid oxidation forms acidic ketone bodies that can result in a toxic 
buildup of keto acids in the body over time (Williamson, 2011). Hypoglycemia can also have 
serious complications such as nephropathy, retinopathy, neuropathy, and cardiovascular disease 
which can ultimately lead to death (WHO, 2013). Hence, a stable glucose concentration is 
essential to avoid serious complications. 
 
 
2.3 Blood Glucose Homeostasis 
In order to maintain normal blood glucose concentrations, people with type 1 diabetes require 
insulin therapy that supplements or replaces the body’s own insulin to maintain near-euglycemia. 
The most common techniques are external insulin administration through multiple daily 
injections (MDI) and insulin pump therapy, also known as Continuous Subcutaneous Insulin 
Infusion (CSII) (Farmer et al., 2008).  
         MDI are subcutaneous injections that are administered manually using either a fine needle 
or an insulin pen.  A slow-acting insulin analog is injected to cover the body’s basal insulin 
needs with additional boluses of fast-acting insulin analog injected in times of high blood 
glucose concentrations, e.g. around mealtimes (Rubin, 2009).  The alternative to MDI is insulin 
pump therapy, which is a continuous insulin infusion system that delivers a fast-acting insulin 
analog subcutaneously. It provides basal insulin continuously throughout the day and delivers 
additional boluses when necessary based on user input (Farmer et al., 2008). Insulin pump 
systems now include automated bolus calculators that can determine the amount of insulin to be 
delivered based on a meal size estimation provided by the user and pre-programmed settings 
including a personalized carbohydrate-to-insulin ratio and an insulin sensitivity factor (Zisser et 
al.,2010).   
          In addition to daily injections or pump therapy, people suffering from type 1 diabetes must 
maintain a healthy diet, exercise regularly, and self-monitor their blood glucose concentration 
throughout the day.  
 
 
2.4 Traditional and Advanced Meal Compensation 
The most common algorithm for determining the required insulin bolus to cover a meal is based 
on the estimated carbohydrate content in the meal as well as the individual insulin-to-
carbohydrate ratio (ICR) determined by medical doctors. This type of insulin dose calculation is 
commonly referred to as carbohydrate (CHO) counting since it is based only on the carbohydrate 
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content (see eq. 9). A more recently developed algorithm for insulin dose calculations was 
presented by Pankowska et al. (Pankowska et al., 2012). It is called the CFP (Carbohydrate, Fat, 
Protein) algorithm and takes into account the fat and protein content in addition to the number of 
carbohydrates. This can be a particularly favorable calculation method for meals that contain 
higher percentages of fat and protein. However, CHO counting remains the most widely used 
algorithm for insulin bolus calculation and is presented in Eq. 1, which shows the CHO Counting 
Algorithm as  
୊ ൌ  ή                                 (1) 
where uF represents the full insulin dose in units of insulin (U), m is the carbohydrate amount in 
grams (g), and ICR denotes the insulin-to-carbohydrate ratio.   
         Insulin pump systems now perform automatic calculations of the insulin dose required to 
cover a certain carbohydrate intake and also provide correction bolus recommendations. 
Examples of automated bolus calculators are the MiniMed Paradigm Bolus Wizard® [Medtronic 
MiniMed, Northridge, CA], Accu-Chek® Combo [Roche Insulin Delivery Systems (IDS), Inc., 
Fishers, IN, a member of the Roche Group], and Animas® 2020 [Animas Corp., West Chester, 
PA, a Johnson and Johnson company]. These devices calculate the insulin dose to be 
administered based on the desired blood glucose concentration, the current blood glucose 
concentration, a personal insulin sensitivity factor and ICR as well as an estimation of the 
carbohydrate amount in the meal. It has been shown that automatic bolus calculators can provide 
good postprandial blood glucose control without causing severe hypoglycemia. However, the 
performance of various automated bolus calculators can vary significantly. This is mainly 
because of differences in the algorithm for calculating the remaining amount of active insulin 
from the initial bolus, but is also due to the algorithmic rules that determine the blood glucose 
concentration to which a correction is made when the pump delivers a correction bolus. (Zisser et 
al., 2010) 
          The insulin regimen for a standard meal in conventional basal-bolus therapy comprises a 
full bolus just before the time of the meal. This type of insulin bolus can work well for certain 
meals, but for slower absorbing meals it is not the optimal compensation method. Recent studies 
suggest that insulin delivered in the form of a dual wave is the optimal compensation method for 
slower absorbing meals such as pizza meals (Jones et al., 2005). Other types of insulin regimens 
that have been considered for such meals are the traditional normal boluses and the square wave 
boluses. However, these regimens have not been as successful at attenuating the blood glucose 
concentration as the dual wave (Chase et al., 2002). The mathematical representations of the 
insulin profiles for a normal bolus, dual wave, and square wave are given in Eqs. 2 – 4, 
respectively.  
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ሺሻ ൌ ୊ ή Ɂሺሻ(2) 
 
ሺሻ ൌ ቊͲǤͷ ή ୊ ή Ɂሺሻǡ ൌ ͲͲǤͷ ή ୊ ή ൫ሺ െ ୗሻ െ ሺ െ ୊ሻ൯ǡ  ൐ Ͳ                          (3) 
 
ሺሻ ൌ ୊ ή ൫ሺሻ െ ሺ െ ୊ሻ൯                                                         (4) 
where t denotes the time post-meal, u(t) is the time dependent insulin infusion in units of insulin 
(U), tS signifies the start of the postprandial period, tF corresponds to the wave duration, δ(t) is a 
discrete unit impulse function, and H(t) represents the Heaviside unit step function. These two 
discrete-time functions are defined in Eqs. 5 and 6, respectively.  
 
Ɂሺሻ ൌ  ቄͳǡ ൌ ͲͲǡ ് Ͳ                                                                           (5) 
 
ሺሻ ൌ  ቄͲǡ ൏ Ͳͳǡ ൒ Ͳ                                                                           (6) 
          The traditional insulin pump offers only a limited number of bolus options, as shown in 
Eqs. 2 – 4, with dual and square wave boluses mainly used for slow absorbing meals. To the 
author’s knowledge, other insulin regimens have not yet been explored. Although the dual wave 
bolus has consistently shown better attenuation than the normal bolus, it has not been verified 
that this is the optimal insulin regimen for slow absorbing meals. 
 
 
2.5 Artificial Pancreas 
The artificial pancreas is a developing technology to help people with type 1 diabetes 
automatically control their blood glucose levels. It combines a glucose sensor, control algorithm, 
and an insulin infusion pump with the purpose of maintaining near-euglycemia through closed 
loop control of the blood glucose concentration (Cobelli et al., 2011). The basic structure of the 
artificial pancreas system (APS) is presented in Fig. 3.  
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          Several control algorithms for this treatment approach have been proposed, with the main 
algorithms being MPC, PID, and more recently fuzzy-logic control. The MPC control strategy is 
attractive for blood glucose control due to its applicability to systems with long time delays as 
well as its potential to anticipate blood glucose concentrations and handle constraints (Soru et al., 
2012). Meanwhile, the PID control and fuzzy-logic algorithms have also shown promising 
results for applications in the APS (Kumareswaran et al., 2012; Liu et al., 2013).   
          An artificial pancreas has been developed by the research group at the University of 
California, Santa Barbara (UCSB) in cooperation with the Sansum Diabetes Research Institute. 
The system uses a zone-MPC control strategy in which the blood glucose concentration is 
controlled within a specified blood glucose concentration zone rather than at a fixed set-point 
(Dassau et al., 2013). Fig. 4 shows an overview of the artificial pancreas system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Overview of the UCSB/Sansum Artificial Pancreas System. 
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Figure 3. Block diagram of the artificial pancreas system (adapted from Doyle et al., 2007). SC denotes subcutaneous  
                glucose measurement. 
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3. Preparatory Analysis and Computations 
The thesis work was performed using the third version of the FDA-accepted University of 
Virginia/Padova (UVA/Padova) metabolic simulator of blood glucose-insulin interactions (Dalla 
man et al., 2007; Breton et al., 2008). It facilitates simulation studies of diabetic individuals and 
can therefore be used in finding the optimal insulin regimen for various meal types in silico.  
         This chapter presents the preparatory analysis and describes the glucose-insulin simulation 
model as well as necessary model modifications that were made. In the current version of the 
simulator, it is only possible to simulate one meal type for which there is no straight forward way 
of altering the meal composition.  Hence, model modifications were necessary to facilitate the 
simulation of slow absorbing high-fat meals.  
 
 
3.1 Effects of Meal Composition  
It is well known that the postprandial blood glucose profile varies significantly with meal size 
and composition. Meals containing large amounts of carbohydrates result in high postprandial 
glucose peaks. In addition, the type of carbohydrate content also influences the glucose profile. 
Glycemic index (GI) is used to rank how fast and high a particular food raises the blood glucose 
concentration compared to pure glucose. This index typically varies with the type of 
carbohydrates because simple carbohydrates are digested faster than complex carbohydrates. 
Examples of foods that are rich in simple carbohydrates are chocolate, fruit juice, and biscuits 
while complex carbohydrates are found in foods such as vegetables as well as whole-grain bread 
and cereals. A low GI is characterized by a slow glucose absorption that results in an extended 
blood glucose profile with a lower peak, while the opposite applies for high glycemic indices 
(Galgani et al., 2006). Indices assigned to meals also vary with meal composition in terms of fat 
and protein content. A higher percentage of fat and protein tends to slow down the rate of 
glucose absorption, which produces a delayed and reduced blood glucose peak compared to low-
fat and low-protein meals containing the same amount of carbohydrates (Normand et al., 2004). 
Fig. 5 illustrates the representative differences in the glucose absorption profile between low- 
and high-fat meals. 
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3.2 Glucose-Insulin Simulation Model 
The UVA/Padova metabolic simulator is based on a mathematical meal model of the glucose-
insulin system developed by Dalla Man et al. (2007). It was constructed based on a data set of 
204 normal individuals and models the physiological events which occur during a standard 
mixed meal in a person. A scheme of the glucose-insulin simulation model is presented in Fig. 6. 
 
 
 
 
 
 
 
 
     
 
 
  
 
Figure 5. Simulated glucose absorption profiles for low- and high-fat meals,  
                each containing 50 g of carbohydrates. The high-fat profile was generated 
                in silico based on data from Normand et al. (2004).  
Figure 6. Glucose-insulin simulation model utilized in the UVA/Padova  
                metabolic simulator (adapted from Dalla Man et al., 2007) 
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Glucose Absorption Model  
The glucose absorption model is one of the sub-models of the glucose-insulin simulation model 
(Dalla Man et al., 2006). It is a nonlinear model describing the transit of glucose through the 
stomach and upper small intestine. The stomach is modeled by two compartments that represent 
the solid and triturated phases of the meal respectively, while the third model compartment 
describes the second part of the digestive tract. A scheme of the glucose absorption model is 
presented in Fig. 7.  
 
 
 
 
 
 
 
 
 
 
 
 
  
The ordinary differential equations that comprise the model are as follows (Dalla Man et al., 
2006):  
 
ሶ ୱ୲୭ଵሺሻ ൌ െଶଵ ή ୱ୲୭ଵሺሻ ൅  ή Ɂሺሻሺʹሻ                          
ሶ ୱ୲୭ଶሺሻ ൌ െୣ୫୮୲ ή ୱ୲୭ଶሺሻ ൅ ଶଵ ή ୱ୲୭ଵሺሻሺ͵ሻ                          
ሶ ୥୳୲ሺሻ ൌ െୟୠୱ ή ୥୳୲ሺሻ ൅ ୣ୫୮୲ ή ୱ୲୭ଶሺሻሺͶሻ 
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The variables qsto1 and qsto2 represent the amounts of solid and liquid phase glucose in the 
stomach, while D is the amount of ingested glucose, δ is the impulse function, qgut is the mass of 
glucose in the intestine, k21 is the grinding rate, kabs is the rate constant of intestinal absorption, 
and f represents the fraction of the absorption that appears in plasma (Dalla Man et al., 2006). 
The rate of gastric emptying is represented by the variable, kempt and is described by a nonlinear 
model as shown in Eqs. 6 – 9: 
 
ୣ୫୮୲ሺୱ୲୭ሻ ൌ ୫୧୬ ൅
୫ୟ୶ െ ୫୧୬
ʹ ή ሼሾȽሺୱ୲୭ െ  ή ሻሿ െ ሾȾሺୱ୲୭ െ  ή ሻሿ ൅ ʹሽሺ͸ሻ 
ୱ୲୭ሺሻ ൌ ୱ୲୭ଵሺሻ ൅ ୱ୲୭ଶሺሻሺ͹ሻ 
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Figure 7. Glucose absorption sub-model (adapted from Dalla Man et al., 2006) 
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The constants kmin and kmax represent the minimum and maximum absorption rates, respectively. 
The parameter b is defined as the percentage of the dose, qsto, for which the rate of gastric 
emptying decreases at the rate (kmax – kmin) / 2, while the parameter c is the percentage of the 
dose for which the rate of gastric emptying is back to (kmax – kmin) / 2 (Dalla Man et al., 2006).  
 
Simulation Model Modifications 
The glucose-insulin model is represented by the Human Model Simulink block in the 
UVA/Padova metabolic simulator, version 3. Since the current version can only simulate one 
meal type, the simulation model was modified to facilitate the simulation of high-fat meals that 
have relatively slow absorption rates. A scheme of the modified model is presented in Fig. 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        The simulation model was modified by the addition of a loop in which an auxiliary meal 
delivery rate can be altered to simulate a slow absorbing meal. The additional loop is marked by 
Figure 8. Modified glucose-insulin simulation model (UVA/Padova Simulator, v3) 
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a blue rectangle in Fig. 8. The meal delivery rate is chosen depending on the absorption rate for a 
particular meal, where a slow meal delivery rate would be appropriate for a slow absorbing meal. 
The subsystem in which the meal characteristics, i.e. carbohydrate content and fictional meal 
delivery rate, are specified is marked by a red rectangle in Fig. 8. When the additional loop is 
switched on, a meal triggers the specified delivery rate until the full meal has been delivered. The 
switch added to the model allows an easy transition between simulation of low-and high-fat 
meals. 
 
 
3.3 In Silico Replication of Published Data  
To ensure realistic simulation data, the auxiliary meal delivery rate was tuned to produce a good 
qualitative replication of postprandial blood glucose profiles in the literature. The simulated 
profiles for the two high-fat meals studied were generated under similar conditions as the 
published data considering the time of the postprandial peak as the criterion for a good match. 
Specifically, the average blood glucose profiles from ten adult in silico subjects were compared 
with published data from Jones et al. (2005) and Normand et al. (2004) under this criterion. 
         Jones et al. conducted a study on 26 adults with type 1 diabetes to determine the optimal 
insulin regimen for a pizza meal. On three separate occasions, the subjects were asked to 
consume three pizza slices consisting of approximately 90 g of carbohydrate, 42 g of fat, 45 g of 
protein, 6 g of fiber, and 6 g of sugar in total. Insulin was delivered as a normal bolus, a 4 or 8-
hour dual wave. They concluded that the 8 hour dual wave was the optimal insulin regimen for a 
pizza meal. 
         Normand et al. performed a study on 9 healthy women to determine the influence of dietary 
fat on postprandial glucose metabolism. One meal consisting of 75 g of pasta with a fat content 
of 55% was chosen from this study for in silico evaluation. Herrero et al. identified certain meal 
model parameters for this particular meal through constrained optimization using the MATLAB 
routine fmincon (Herrero et al., 2007). These parameter values were implemented in the 
UVA/Padova metabolic model to obtain the glucose absorption profile for a high-fat pasta meal 
in silico. The scenario was simulated under subject specific optimal basal insulin therapy and 
appeared a realistic estimate of the glucose absorption profile for a high-fat meal when compared 
to clinical data from the type 1 diabetes study conducted by Jones et al. (2004). This particular 
blood glucose profile will hereafter be referred to as the reference profile. As mentioned 
previously, the optimized model parameter values could not be used when simulating regular 
open- or closed-loop insulin therapy as it resulted in unrealistic blood glucose dynamics when 
administering insulin in addition to the basal insulin rate. Hence, the optimized parameters were 
only used to obtain a simulated reference profile under basal insulin therapy. This profile was 
then used to generate a glucose absorption profile for a high-fat pasta meal by altering the 
auxiliary meal delivery rate in the modified metabolic simulator (see Chap. 3.2, section: 
Simulation Model Modifications), as shown in Fig. 9b. 
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         Both the pizza and pasta meals were simulated in silico and were programmed as 90 g and 
63.4 g carbohydrate meals, respectively. These amounts are based on published data from Jones 
et al. (2005) and Normand et al. (2004). The modified glucose-insulin simulation model was then 
programmed to deliver the meals at slower rates to match the given data. Altering the auxiliary 
meal delivery rate made it possible to replicate the time of the peak, but since the delivery rate 
does not affect the magnitude of the postprandial glucose excursion, the height of the blood 
glucose peak could not be adjusted.  The peak height for the simulated pizza meal conforms to 
published data and hence did not require adjustment, but there remains a quantitative mismatch 
for the high-fat pasta meal due to the inability to adjust the postprandial peak height. However, in 
connection with the insulin regimen optimization, the time of the peak is of greater interest than 
the peak height since this will determine the optimal timing for all insulin deliveries. After fine-
tuning the auxiliary meal delivery rates, it was possible to qualitatively replicate the reference 
profiles, as shown in Fig. 9.  
 
 
 
 
         Since the meal delivery rates vary with the size of the meal, the obtained values for both 
meal types were translated into auxiliary meal durations that are independent of meal size. The 
durations for the pizza and high-fat pasta meals were determined to be 175 and 300 minutes, 
respectively. With constant meal durations it is thus possible to simulate these two meal types for 
varying amounts of carbohydrates.   
        Fig. 10 illustrates the scope of this thesis work, i.e. the different meal types that were 
studied. The figure presents the ten subject average blood glucose absorption profiles for the 
three different meal types of similar size: a low-fat meal, pizza meal, and high-fat pasta meal.  
Figure 9b. Comparison of simulated ten subject average blood 
                  glucose response profiles for a 63.4 g CHO high-fat 
                  pasta meal and a simulated reference profile based  
                  on in silico data from Herrero et al.  (2007). The 
                  scenarios were simulated under basal insulin therapy 
                  only. 
Figure 9a. Comparison of simulated ten subject average blood  
                 glucose response to a 90 g CHO pizza meal and  
                 published data from Jones et al. given a full insulin  
                 bolus at the time of the meal (Jones et al., 2005)        
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         The simulated profiles shown in Fig. 10 clearly show the significant variations in glucose 
absorption with meal composition, with the high-fat pasta meal having the slowest absorption 
rate due to its high fat content. Table 1 presents certain parameters, such as area under the curve 
(AUC), blood glucose peak, and time of peak for the simulation of these three meal types under 
simple basal insulin therapy to demonstrate the effect of increased fat content on glucose 
absorption. These parameters are commonly used in combination with other metrics to measure 
controller performance and evaluate open-loop control systems for diabetes treatment. The area 
under the curve (AUC) is a measure of the deviation from the baseline and was calculated with a 
baseline of 110 mg/dl (mid-euglycemic range). It was then normalized through division by the 
simulation time and can thus easily be compared between simulations independent of simulation 
time.  
 
Table 1. Comparison of a low-fat meal, pizza meal, and high-fat pasta meal. The  
              presented values are averaged over ten in silico subjects.  
Meal Type Mean Blood Glucose 
Peak (mg/dl) 
Time of Peak 
(minutes post meal) 
Normalized AUC 
(mg/dl) 
Low-fat 234.8 ± 38.9 2.6 ± 0.6 33.5 ± 17.0 
Pizza  226.2 ± 38.7 4.6 ± 0.6 33.3 ± 16.8 
High-fat Pasta 214.2 ± 37.9 6.4 ± 0.5 33.1 ± 16.1 
 
Figure 10. Ten subject average glucose absorption profiles for three  
                  different meal types, each containing 50 g of carbohydrates.  
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         Both the blood glucose peak and the time of peak vary significantly between the three meal 
types as shown in table 1. An increased fat percentage slows down the rate of glucose absorption 
which causes a delayed and reduced blood glucose peak for high-fat meals. As expected, the 
difference in normalized AUC between the three meals is negligible since they contain the same 
amount of carbohydrates. The ability to simulate both low- and high-fat meals in the modified 
metabolic simulator was then used to find the optimal insulin regimens for these three meal 
types.  
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4. Meal Compensation 
Meal compensation is one of the biggest challenges in blood glucose control due to the variations 
in glucose response with different meal compositions as well as the difficulties in estimating the 
exact carbohydrate content in meals consumed. Since different meals produce diverse glucose 
absorption profiles, it is not optimal to compensate for all meals using the same insulin delivery 
regimen. It has been consistently reported that administering a normal bolus is not optimal for 
high-fat meals due to the slow rise in blood glucose (Chase et al., 2002; Jones et al., 2005). It is 
very important to consider this absorption delay when designing an insulin regimen for meals of 
this type, and many recent studies have aimed at determining the optimal insulin regimen for 
high-fat meals to address this issue (Chase et al., 2002; Jones et al., 2005; Scaramuzza et al., 
2007).  
 
 
4.1 Novel Open-loop Insulin Regimens for Low and High-fat Meals 
The motivation for exploring novel insulin regimens is to improve postprandial blood glucose 
control in people with type 1 diabetes. Since the meal absorption rate depends on meal 
composition, the insulin regimen should be altered between the different meal types to obtain 
optimal blood glucose control. Administering a normal bolus for a high-fat meal increases the 
risk of postprandial hypoglycemia because the meal absorption is slower than the insulin 
absorption and action. In silico testing of various insulin regimens revealed that both open- and 
closed-loop blood glucose control following high-fat meals could be enhanced by an insulin 
regimen consisting of multiple deliveries in the form of insulin waves. 
         The insulin regimen for a given meal type was formulated as an optimization problem and 
is explained in further detail in Appendix A. Each meal scenario problem was solved using the 
UVA/Padova metabolic simulator, taking into account ten adult in silico subjects.  Three 
different meal types were considered for the insulin regimen optimization: a standard low-fat 
meal, a pizza meal, and a high-fat pasta meal. Each of these was simulated as 50 g, 75 g, and 100 
g carbohydrate meals, providing a total of nine different scenarios. The standard low-fat meal is 
the default meal type in the metabolic simulator, while the simulated pizza and pasta meals are 
based on published data. The aim of creating an insulin regimen optimizer is to provide a way of 
giving appropriate insulin bolus recommendations to patients for various meal types.  
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Insulin Regimen Optimization 
The Particle Swarm Optimization (PSO) methodology was first introduced by James Kennedy 
and Russell C. Eberhart in 1995. It is a biologically inspired algorithm that has been proven 
efficient in solving optimization problems. PSO is a population based algorithm in which a set of 
potential solutions are improved iteratively based on the given cost function that is to be 
minimized. Each member (particle) of the population is a potential solution and is initialized 
with a velocity and position in the parameter space. During the optimization, the particles are 
moved around in the D-dimensional search space where D is the number of optimization 
variables. The aim is to progressively move the entire particle population to the optimal solution, 
i.e. the optimal combination of the optimization variables (Kennedy et al., 1995). Fig. 11 
presents the basic concept of the PSO algorithm.  
 
 
 
 
 
 
 
 
 
         Fig. 11 presents the basic PSO algorithm applied to a two variable optimization problem by 
illustrating the movement of candidate solutions (particles) in the search space. Each particle in 
Fig. 11 represents a particular combination of the two optimization variables, n and m, and are 
uniformly distributed over the search space. In the PSO algorithm, each particle is described by 
four vectors in the D-dimensional space: its current position Xi = (xi1, xi2, . . . , xiD), its velocity 
Vi = (vi1, vi2, . . . , viD), its currently best found position Pi = (pi1, pi2, . . . , piD), and the currently 
best position searched by the whole particle swarm Pg = (pg1, pg2, . . . , pgD). Each particle’s 
position is updated iteratively as shown in Eqs. 10 – 11 (Kennedy et al., 1995):  
୧୲ାଵ ൌ  ή ୧୲ ൅ ଵଵ ή ൫୧୲ െ ୧୲൯ ൅ ଶଶ ή ൫୥୲ െ ୧୲൯(10) 
୧୲ାଵ ൌ ୧୲ ൅ ୧୲ାଵ(11) 
where in Eq. 10, w is a scaling factor that determines the influence of the previous velocity on 
the updated one. The constants c1 and c2 are cognitive and social coefficients, respectively and 
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Figure 11. The basic concept of the Particle Swarm Optimization algorithm 
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determine the local and global influence on the updated velocity. The parameters r1 and r2 are 
random numbers that are generated from a uniform distribution in the interval [0,1].   
(Kennedy et al., 1995) 
         The algorithm evaluates each particle’s position according to the given cost function and 
updates the particle’s best found position if the current position is better than any previous 
position it had. Thereafter, the best found position so far is determined based on all particles’ 
previous best positions. The algorithm then goes on to update each particle’s velocity, which is 
influenced by the particle’s inertia, its best position, and the global best position as shown in Fig. 
11 and Eq. 10. The influence of these three variables is determined by the weighting parameters 
w, c1, and c2. Given the updated velocities, each particle’s position can be updated according to 
Eq. 11, after which all particles are moved to their new positions. The objective is to 
progressively move the entire population closer to the optimal solution and eventually arrive at 
the optimal combination of the optimization variables as shown in the right hand side of Fig. 11. 
         In this study, the PSO algorithm was implemented to find the optimal open-loop insulin 
regimens for three different meal types. It was also used to find the optimal insulin regimen 
under a closed-loop setting with a PID controller for which the controller parameters were also 
optimized using the same methodology (see Chap. 4.2 Novel Closed-loop Insulin Regimens for 
Low- and High-fat Meals). For both the open- as well as closed-loop cases, the insulin regimen 
optimization problem was designed as a multiple delivery scheme with four possible deliveries. 
However, the bounds for each delivery were chosen so that the deliveries are made only if it is 
optimal (see Appendix A). The three chosen optimization variables for each delivery are: the 
time of the insulin delivery, the fraction of the full insulin dose to be delivered, and the time 
duration of each delivery, resulting in a total of 12 variables for the given problem. The 
computational parameters, including constraints as well as upper and lower limits are presented 
in Appendix A.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Open-loop Regimens for Low-fat Meals 
General optimal insulin regimens (GOR) for ten in silico subjects given low-fat meals 
comprising 50, 75, and 100 g of carbohydrates were determined using PSO. The optimization 
result for a low-fat meal containing 100 g of carbohydrates is presented in Fig. 12 and the results 
for 50 and 75 g low-fat meals in Appendix B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          The results in Fig. 12 show that the optimal insulin regimen for a low-fat meal comprising 
100 g of carbohydrates is a 15 minute wave delivered 30 minutes prior to the meal. However, the 
optimal insulin regimen for a 50 and 75 g carbohydrate low-fat meal is a normal bolus delivered 
30 minutes before the meal (see Appendix B). Although early insulin administration is 
theoretically optimal, it is important to consider the potential risks of hypoglycemia if the meal is 
delayed. Theoretically, the results are feasible considering the increased risk of hypoglycemia 
that follows a normal bolus when compensating for larger meals. However, it is important to 
note that these results were obtained because the earliest possible insulin delivery was 
constrained to 30 minutes prior to the meal due to the practical difficulties of meal planning. 
Since the meal is large and fast absorbing, it is difficult to maintain the blood glucose 
concentrations for all ten subjects within the safe range of 70 – 180 mg/dl, as shown in Fig. 12. 
The results for all three meal sizes suggest that insulin should be administered at least 30 minutes 
Figure 12. General optimal open-loop insulin regimen for a low-fat meal  
                  comprising100 g of carbohydrates. The upper plot shows the  
                  postprandial blood glucose response profiles for ten in silico subjects,  
                  and the bottom plot presents the optimal insulin delivery pattern for  
                  all ten subjects. The optimized insulin delivery regimen maintains a  
                  majority of the subjects within the 70-180 mg/dl safe zone throughout  
                  the trial despite the high carbohydrate content of the meal. 
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before the start of the meal for low-fat meals of significant size. This is explained further by the 
simulated intestinal glucose absorption profiles for this meal type in Fig. 13.  
 
 
 
 
.  
 
 
 
 
 
 
 
          The fast digestion of low-fat meals causes a rapid glucose absorption, as shown in Fig. 13. 
The glucose absorption peaks occur approximately 30 minutes after the start of the meal. The 
absorption of glucose is relatively fast compared to the time needed for insulin absorption and 
action since insulin is delivered subcutaneously as per current technology. It is therefore 
necessary to administer the insulin prior to the meal to avoid severe hyperglycemia, as proposed 
by the general regimen presented in Fig. 12.  
         Optimal regimens for each individual subject were also determined to confirm that the 
general regimen is feasible, and to find potential trends that may be used as guidelines when 
prescribing regimens to certain groups of patients. The individually optimized regimens (IOR) 
for a 100 g low-fat meal are shown in Fig. 14.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Ten subject average intestinal glucose absorption profile for  
                  low-fat meals comprising 50, 75, and 100 g of carbohydrates.                   
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         As shown in Fig. 14, although a few subjects display an extended wave pattern, most of the 
individual regimens comprise one short square wave. These results validate the general regimen 
since all individual insulin profiles are very similar to the general optimal regimen in Fig. 12. 
Fig. 15 presents the individual regimens on a normalized scale and compares the average insulin 
profile to the general optimal regimen.  
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Figure 14. Individual optimal open-loop insulin regimens for a low-fat meal  
                  comprising 100 g of carbohydrates. The upper plot shows the postprandial 
                  blood glucose profiles for ten in silico subjects, and the bottom plot  
                  presents the individual optimal insulin delivery patterns for all ten  
                  subjects.  
Figure 15b. Comparison between the average insulin profile  
                    based on individually optimized regimens and 
                    the general regimen optimized for ten in silico 
                    subjects given a low-fat meal comprising 100 g  
                    of carbohydrates. 
Figure 15a. The optimized individual insulin delivery patterns 
                   for ten in silico subjects and the average insulin 
                   profile based on the individual patterns given a 
                   low-fat meal comprising 100 g of carbohydrates. 
35 
 
-1 0 1
0
25
50
Time Post Meal (h)
Pe
rc
en
ta
ge
 o
f D
os
e 
(%
)
Short Square Wave
 
 
ICR: 1/22
ICR: 1/20
ICR: 1/9
ICR: 1/20
ICR: 1/14
-1 0 1
0
25
50
Time Post Meal (h)
Pe
rc
en
ta
ge
 o
f D
os
e 
(%
)
Extended Wave
 
 
ICR: 1/19
ICR: 1/15
ICR: 1/13
ICR: 1/18
ICR: 1/9
         The similarities between the general regimen and the average insulin profile indicate that 
providing a general recommendation to patients can be reasonable for this meal type. However, 
there are slight variations between the individual regimens, as shown in Fig. 16, which compares 
two distinguishable wave patterns.   
 
 
 
 
         The results in Fig. 16 show that 50% of the subjects have optimized individual regimens 
comprising a short square wave, while the others have an extended wave pattern. Although the 
exact reason for these profile variations could not be linked to the ICR, the results are not 
unrealistic as other biological effects such as the insulin absorption rate, fitness, and others may 
also play a role in a subject’s blood glucose response. Interestingly, there appears to be a small 
but consistent trend for highly sensitive subjects (low ICR), since they all have short square wave 
profiles, as shown in the left hand side of Fig. 16. This indicates that subjects with high insulin 
sensitivities may benefit further from a slower infusion rate due to the relatively faster insulin 
action in these subjects.  
         To confirm the optimality of the obtained results, the performance of the general and 
individual regimens is compared to that of a normal bolus delivered 30 minutes prior to the meal 
in Fig. 17.  
 
 
 
 
 
 
Figure 16. Observed trends in insulin profiles for ten in silico subjects. The left plot shows the group of in silico  
                  subjects whose optimal insulin delivery regimen comprises one short square wave, and the right plot  
                  presents the group of subjects whose individual regimens have an extended wave pattern. ICR denotes the  
                  insulin-to-carbohydrate ratio and is a measure of insulin sensitivity.  
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         Fig. 17 shows that the performance of the three insulin regimens is almost indistinguishable 
since they all produce similar average blood glucose profiles and ranges of variability. For a fast 
absorbing low-fat meal there are only a limited number of insulin regimens that will provide 
good blood glucose control, which is why the results for the various regimens are similar. This is 
also confirmed by the data in Table 2, which provides a comparison of the regimens by a set of 
performance metrics, averaged over ten in silico subjects.  
 
Table 2. Comparison of three insulin regimens for a low-fat 100 g carbohydrate meal.  
Insulin 
Regimen 
Normalized 
AUC (mg/dl) 
Mean % Time 
within  
70-180 mg/dl 
Mean % Time 
within  
80-140 mg/dl 
Mean Blood Glucose 
Peak (mg/dl) 
General 
Regimen 9.9 ± 2.1 97.6 ± 2.5 91.4 ± 3.1 186.8 ± 13.9 
Individual 
Regimen 9.8 ± 2.1 97.6 ± 2.5 91.2 ± 3.0 186.9 ± 14.6 
Normal Bolus 
30 Minutes 
Prior to Meal 
9.8 ± 2.2 97.5 ± 2.8 90.3 ± 3.4 185.0 ± 14.7 
 
 
          Although the results in Table 2 show similar performance for all three regimens, it is 
important to note that the general and individual optimal regimens show lower standard 
deviation for all measured parameters and can maintain blood glucose concentrations within the 
Figure 17. Comparison of the optimal regimens and a normal bolus delivered 30 minutes prior to a low-fat meal comprising  
                  100 g of carbohydrates. The solid curves represent the average blood glucose profiles for ten in silico subjects and 
                  the area between the dashed lines shows the range of variability.                      
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euglycemic range marginally longer than the normal bolus. A statistical paired t-test with an α-
level of 0.05 confirms that the normal bolus regimen is close to optimal since it shows that the 
optimal general regimen is significantly better only in terms of the percentage of time spent in 
euglycemia. Furthermore, a paired t-test comparing the general and individual regimens revealed 
that the individually optimized regimens are not significantly better, suggesting that a general 
recommendation can be used for this meal type.  
         Observations of the overall results for low-fat meals (100, 75, and 50 g carbohydrate 
content) suggest that meals of significant size should be announced at least 30 minutes prior to 
the meal for optimal blood glucose control. The best meal compensation is achieved by a normal 
bolus or a short square wave depending on the size of the meal. 
 
 
Open-loop Regimens for High-fat Pizza Meals 
Next, the generalized optimal insulin regimens for high-fat pizza meals of various sizes were 
found using PSO. Results for meals containing 50 and 75 g of carbohydrates are presented in 
Appendix B, and the result for a 100 g pizza meal is shown in Fig. 18.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         The results in Fig. 18 show that the general optimal insulin regimen for a large pizza meal 
comprises two consecutive square waves of similar lengths. This biphasic regimen maintains the 
Figure 18. Optimal open-loop insulin regimen for a high-fat pizza meal containing  
                  100 g of carbohydrates. The upper plot shows the postprandial  
                  blood glucose profiles for ten in silico subjects, and the bottom plot 
                  presents the optimal insulin delivery pattern for all ten subjects. The  
                  optimized insulin delivery regimen maintains safe blood glucose concentrations 
                  for all subjects throughout the trial despite the high carbohydrate content of the meal 
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blood glucose concentration within the range of 70 – 180 mg/dl for most subjects and results in 
only one mild hyperglycemic event.  The general regimen for a 75 g pizza meal is similar to that 
for the 100 g meal presented in Fig. 18. However, the result obtained for a 50 g meal suggests 
that a long square wave provides better compensation for smaller meal sizes (see Appendix B). 
The slower insulin delivery in the form of a single wave can be explained by the relatively slow 
blood glucose excursion for smaller meals of this type, as illustrated by the simulated glucose 
absorption profiles in Fig. 19.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         High-fat meals such as pizza meals generally exhibit slow glucose absorption as a result of 
the longer digestion process. The absorption peaks for these particular pizza meals occur 
approximately 2 hours and 40 minutes after the start of the meal. The glucose absorption is 
relatively slow compared to the time needed for insulin absorption and action, which is why the 
general optimal regimen does not suggest insulin delivery prior to the meal. Insulin 
administration that is too early could potentially result in hypoglycemia because of the slow 
digestion. The optimization results for all three pizza meals propose regimens in which the 
insulin deliveries are made within the first two hours after the start of the meal. The time of the 
glucose absorption peak is similar for all three meal sizes and is what determines this specific 
time period for insulin deliveries. As mentioned previously, the results suggest that biphasic 
regimens are more favorable when consuming larger meals. This is feasible since larger meals 
cause a faster rise in glucose concentration compared to smaller meals, as indicated by the 
glucose absorption profiles in Fig. 19.  
         Individual optimal regimens were also determined for each of the ten subjects to examine 
potential trends that might be useful in prescribing insulin regimens to patients. The individual 
optimal insulin regimens for a 100 g high-fat pizza meal are shown in Fig. 20.  
Figure 19. Ten subject average intestinal glucose absorption profiles for high-fat 
                  pizza meals comprising 50, 75, and 100 g of carbohydrates. 
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         Most of the individual regimens display biphasic patterns that are similar to the general 
optimal regimen. Although some subjects have multiphasic regimens, the biphasic pattern is the 
most common among the individual regimens. This implies that the general regimen in Fig. 14 
conforms to the results from the individual optimizations. With the general regimen, insulin is 
delivered within the first two hours of the meal, following the same trend as most of the 
individual insulin regimens in Fig. 20. Fig. 21 presents the various individual regimens and 
compares the average insulin profile to the general optimal regimen. 
 
 
 
 
 
Figure 20. Individual optimal open-loop insulin regimens for a high-fat pizza meal  
                 comprising 100 g of carbohydrates. The upper plot shows the postprandial 
                  blood glucose profiles for ten in silico subjects, and the bottom plot  
                  presents the individual optimal insulin delivery patterns for all ten  
                  subjects. 
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         The insulin deliveries in the general regimen occur approximately at the same time as the 
peaks of the average insulin profile, which indicates that the regimen is a reasonable 
recommendation for this meal type. However, there are significant variations between the 
individual regimens as a result of various factors, making it difficult to recognize clear trends. 
One of the main factors determining the insulin regimens appears to be the ICR. Fig. 22 
illustrates the various trends that can be observed between different groups of subjects.  
 
 
         The left hand side of Fig. 22 shows that the most consistent trend can be observed for the 
most insulin sensitive subjects with ICRs near 1/20. The regimens are very similar in terms of 
Figure 21a. The optimized individual delivery patterns for ten 
                    in silico subjects and the average insulin profile  
                    based on the ten individual patterns given a pizza 
                    meal comprising 100 g of carbohydrates.  
Figure 21b. Comparison between the average insulin  
                    profile based on individually optimized regimens 
                    (IOR) and the general regimen optimized for ten 
                    in silico subjects. 
Figure 22. Observed trends in insulin profiles for ten in silico subjects. The left plot shows the group of in silico subjects with the  
                  highest insulin sensitivities and whose individual optimal insulin regimens are biphasic. The middle plot presents 
                  another group of subjects that have biphasic insulin delivery patterns, and the right plot shows the subjects whose 
                  insulin regimens are multiphasic. 
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the biphasic pattern and the time of insulin deliveries, which suggests that this may be an 
appropriate regimen for highly sensitive patients. However, no clear trend could be observed for 
subjects with lower insulin sensitivity. While most subjects are recommended a biphasic 
regimen, there are a few subjects that have multiphasic insulin profiles (right hand side of Fig. 
22). Although it is natural that less sensitive subjects require multiple fast insulin deliveries to 
keep the blood glucose concentration from rising too high, no clear trend could be linked to the 
ICR. This is possibly because other factors, such as insulin absorption rate, also affect the 
appearance of the recommended regimens. However, for highly sensitive subjects the ICR seems 
to be the dominant factor.  
         To confirm the obtained results, the optimal regimens were compared to schemes that are 
currently offered by traditional insulin pumps.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Fig. 23 shows that it is difficult to distinguish the performance of the general, individual 
and square wave regimens since all three maintain most subjects within the range of 70 – 180 
mg/dl with limited cases of hyperglycemia. The data presented in Table 3 provide a clearer 
comparison of the regimens. 
 
 
 
 
Figure 23. Comparison of insulin regimens for a pizza meal comprising 100 g of  
                 carbohydrates. The solid curves represent the average blood glucose 
                 profiles for ten in silico subjects. The area between the dashed lines shows 
                 the range of variability.                   
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Table 3. Comparison of various insulin regimens for a 100 g carbohydrate pizza meal 
Insulin 
Regimen 
Normalized 
AUC (mg/dl) 
Mean % Time 
within  
70-180 mg/dl 
Mean % Time 
within  
80-140 mg/dl 
Mean Blood Glucose 
Peak (mg/dl) 
General 
Regimen 8.5 ± 2.2 99.8 ± 0.7 91.7 ± 4.2 157.8 ± 15.6 
Individual 
Regimen 8.0 ± 2.0 99.6 ± 0.8 91.3 ± 3.5 160.2 ± 15.3 
Normal Bolus 12.7 ± 7.7 96.5 ± 6.5 84.2 ± 9.0 179.9 ± 23.3 
2 Hour Dual 
Wave 9.1 ± 3.8 98.8 ± 2.6 88.9 ± 5.0 168.1 ± 18.7 
2 Hour Square 
Wave 9.3 ± 2.1 99.6 ± 0.8 89.6 ± 4.5 161.3 ± 15.7 
 
         Table 3 shows that the individual optimal regimens perform better since they have a lower 
average AUC. The general and square wave regimens perform relatively well in terms of the 
percentage of time in euglycemia as well as the average blood glucose peak. However, the 
square wave regimen results in a significantly higher average AUC. Paired t-tests with an α-level 
of 0.05 were performed to compare the general and square wave regimens as well as the general 
and individual regimens, respectively. The statistical results reveal that the generalized optimal 
regimen performs significantly better than the square wave in terms of the time spent in 
euglycemia, the postprandial blood glucose peak as well as the normalized AUC. Furthermore, 
the statistical difference in performance between the general and individual regimens is 
insignificant, indicating that the general optimal regimen could be implemented as a common 
recommendation to patients when consuming similar meals.   
         The overall optimization results suggest biphasic regimens for larger high-fat pizza meals, 
while a square wave regimen appears to perform better for smaller meal sizes. The optimal 
regimens are all characterized by insulin deliveries within an approximate 2 hour postprandial 
period, independent of meal size. 
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Open-loop Regimens for High-fat Pasta Meals 
Finally, the general optimal insulin regimens for high-fat pasta meals of various sizes were 
determined using PSO. The insulin regimens for meals comprising 50 and 75 g of carbohydrates 
can be found in Appendix B, and the general regimen for a 100 g carbohydrate high-fat pasta 
meal in Fig. 24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         The result in Fig. 24 is an insulin regimen optimized for ten in silico subjects and 
comprises four consecutive waves of varying lengths. The recommended general regimen 
provides good blood glucose control for all ten in silico subjects, with all but one subject being 
maintained within the range of 70 – 180 mg/dl. However, it is important to recognize the 
difficulty of prescribing a general regimen for large meals since not all patients are equally 
sensitive to insulin. The general optimal regimens for 50 g and 75 g carbohydrate pasta meals are 
biphasic and triphasic, respectively. This indicates that the number of waves in the general 
regimen increases with meal size. The observed multiphasic insulin profiles are feasible 
considering the simulated glucose absorption profiles for high-fat pasta meals presented in Fig. 
25.  
 
 
 
Figure 24. Generalized optimal open-loop insulin regimen for a high-fat pasta meal  
                  comprising 100 g of carbohydrates. The upper plot shows the postprandial 
                  blood glucose profiles for ten in silico subjects, and the bottom plot presents 
                  the optimal insulin deliver pattern for all ten subjects. The optimized delivery  
                  regimen maintains all but one subject in the 70-180 mg/dl safe zone despite  
                  the high carbohydrate content.  
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         The blood glucose peaks for the high-fat pasta meals occur approximately 6 hours after the 
start of the meal because the fat content in meals generally slow down glucose absorption. Since 
the rise in blood glucose is slow compared to the rate of insulin absorption and action, it seems 
appropriate to administer the insulin dose shortly after the start of the meal as suggested by the 
general optimal regimen in Fig. 24. Delivering insulin too early increases the risk for immediate 
hypoglycemia for this type of meal due to the slow glucose absorption. The optimization results 
propose regimens in which all the insulin deliveries are made within the first four hours after the 
start of the meal. This time interval is dependent on the time of the blood glucose peak that is 
similar for all meal sizes as shown in Fig. 25.The results also suggest that the number of waves 
in the regimen should increase with meal size, which can be explained by the relatively fast rise 
in blood glucose concentration resulting from larger meals. However, this is assuming that the 
meal duration is independent of meal size. The increasing number of waves is thus feasible since 
it is apparent that a faster increase in blood glucose requires multiple frequent deliveries of 
insulin to keep the blood glucose from rising too high. Smaller meals result in a slower rise in 
glucose which allows for longer gaps between the insulin deliveries.  
         Individual optimizations were also performed for the ten subjects with the aim of finding 
consistent trends that could be useful when prescribing insulin regimens to patients. The 
individual optimal insulin regimens for a 100 g high-fat pasta meal are presented in Fig. 26.  
 
 
 
 
 
Figure 25. Ten subject average intestinal glucose absorption profiles for high-fat 
                  pasta meals comprising 50, 75, and 100 g of carbohydrates 
45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         These individual insulin regimens all have multiphasic patterns with the number of waves 
ranging from two to four. The patterns are similar to the general optimal regimen, with all insulin 
also being delivered within a four hour postprandial period. Fig. 27 presents the individual 
regimens together with the average insulin profile and offers a comparison between the average 
and general regimen. 
 
Figure 26. Individual optimal open-loop insulin regimens for a high-fat pasta meal  
                 comprising 100 g of carbohydrates. The upper plot shows the postprandial 
                 blood glucose profiles for ten in silico subjects, and the bottom plot  
                 presents the individual optimal insulin delivery patterns for all ten subjects. 
Figure 27a. The optimized individual delivery patterns for ten in 
                    silico subjects and the average insulin profile based on 
                   the ten individual patterns given a high-fat pasta meal 
                   comprising 100 g of carbohydrates.  
Figure 27b. Comparison between the average insulin profile  
                   based on individually optimized regimens (IOR)  
                   and the general regimen optimized for ten  
                   in silico subjects. 
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         Fig. 27a shows the average insulin profile based on the individual optimal regimens, while 
a direct comparison of the average profile with the general optimal regimen is presented in Fig. 
27b. This comparison clearly shows that the general regimen is reasonable since the insulin 
deliveries occur around the same time as the main peaks of the average insulin profile. The 
variations in insulin regimens are a result of many different factors which is why it is difficult to 
recognize clear trends in the proposed insulin regimens. However, one of the main factors in 
determining the regimen design appears to be the ICR. In Fig. 28, the individual optimal 
regimens for subjects with low ICR (൑ ͳȀͳͶ) and high ICR (൒ ͳȀͳͶ) are grouped to display the 
trends that occur due to differences in insulin sensitivity.  
 
         Although it is difficult to recognize clear trends in the insulin regimens, the most visible 
trend is that subjects with high insulin sensitivity (see Fig. 28a) are recommended a biphasic 
regimen. A clear trend for these subjects is that the first insulin wave is delivered within a two 
hour postprandial period, while the second wave is delivered between two and four hours after 
the start of the meal. However, one subject deviates from this time pattern, possibly due to the 
relatively low insulin sensitivity (ICR: 1/14). The biphasic regimens are realistic considering that 
multiple insulin waves might cause increased fluctuations in blood glucose concentration for 
sensitive subjects.  Biphasic regimens with longer insulin waves provide slower insulin infusion, 
which is desirable for more sensitive patients. Fig. 28b shows that the individual optimal 
regimens for the less insulin sensitive subjects are multiphasic. The regimens are characterized 
by an initial long wave followed by short waves lasting up to 15 minutes. Intuitively, less 
sensitive subjects would require faster and more frequent insulin deliveries to keep the blood 
glucose from rising too high. This explains the higher number of short insulin spikes in the 
regimens presented in Fig. 28b.  
 
Figure 28a. Trends in individually optimized regimens for  
                    subjects with high insulin sensitivity. The plot  
                    shows a biphasic insulin delivery pattern for  
                    highly sensitive subjects. 
Figure 28b. Trends in individual optimal regimens for subjects  
                    with low insulin sensitivity. The plot shows  
                    multiphasic insulin delivery patterns for less  
                    sensitive subjects.  
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         To confirm that the obtained results are optimal, the general and individual regimens were 
compared to the ones currently offered by traditional insulin pumps. Fig. 29 compares the 
performance of the optimal insulin regimens for a 100 g pasta meal to that of a dual wave and 
square wave delivered at the time of the meal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
          Fig. 29 shows that the general optimal regimen provides better control of the postprandial 
glucose excursion than a dual and square wave. The 4 hour dual wave results in hypo- and 
hyperglycemia for some subjects, while the 4 hour square wave performs relatively well. 
However, the upper blood glucose range for the square wave regimen is above 140 mg/dl for an 
extended period of time. The general optimal regimen is able to maintain euglycemia for a longer 
time period, although it is apparent that individualized optimal regimens result in better blood 
glucose control than the other suggested regimens for this meal type. Table 4 compares the 
performance of different regimens in terms of the normalized AUC, the percentage of time spent 
in the different blood glucose zones, as well as the glucose peak.  
 
 
 
 
 
Figure 29. Comparison of insulin regimens for a high-fat pasta meal comprising  
                  100 g of carbohydrates. The solid curves represent the average blood glucose 
                  profiles for ten in silico subjects. The area between the dashed lines shows 
                  the range of variability.                   
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Table 4. Comparison of various insulin regimens for a 100 g carbohydrate pasta meal 
Insulin 
Regimen 
Normalized 
AUC (mg/dl) 
Mean % Time 
within  
70-180 mg/dl 
Mean % Time 
within  
80-140 mg/dl 
Mean Blood Glucose 
Peak (mg/dl) 
General 
Regimen 8.3 ± 4.0 99.4 ± 1.9 91.6 ± 6.2 159.3 ± 15.1 
Individual 
Regimen 7.7 ± 2.7 100 94.3 ± 4.2 152.3 ± 12.1 
Normal Bolus 18.9 ± 12.1 88.5 ± 9.1 75.5 ± 11.2 192.1 ± 33.6 
4 Hour Dual 
Wave 9.8 ± 4.7 98.6 ± 3.9 88.5 ± 7.5 166.5 ± 14.1 
4 Hour Square 
Wave 9.6 ± 2.9 100 90.4 ± 6.9 153.2 ± 12.5 
 
         The data presented in Table 4 show that the individualized optimal regimens result in 
overall better performance than the other regimens. This was also confirmed by a statistical t-
test, which showed that the individual schemes perform significantly better than the general in 
terms of the time spent in euglycemia as well as the postprandial blood glucose peak. Although 
the 4 hour square wave performs relatively well, it is clear that the optimized regimens show 
consistently better performance since they yield average normalized AUCs below 9 mg/dl and 
the percentage of time in euglycemia is above 90%. However, the results from a statistical 
comparison between the general regimen and the square wave are inconclusive as they show no 
significant difference in performance, although the difference in normalized AUC is close to 
being significant. These results suggest the need for more extensive in silico testing with a larger 
subject population. 
         Even though the general regimen does not perform as well as the individual regimens, it is 
still able to maintain near-euglycemia for most in silico subjects with a relatively low average 
normalized AUC. With an overall good performance in comparison to the individual regimens, 
the general regimen could potentially be implemented as a common recommendation to patients 
when consuming similar meals.  
         The overall optimization results suggest that the best general insulin regimens for high-fat 
pasta meals of various sizes are multiphasic regimens. This was also confirmed by the individual 
optimization results. All the optimized regimens are characterized by insulin deliveries within a 
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four hour postprandial period with a varying number of insulin waves depending on the size of 
the meal.  
 
Summary of Novel Open-loop Regimens 
The particle swarm optimizations of open-loop insulin regimens yielded novel regimens for all 
three meal types studied. The optimal insulin delivery regimens for low-fat meals comprise a 
normal bolus or short square wave delivered at least 30 minutes prior to the meal, whereas the 
optimal regimens for pizza meals include square wave and biphasic regimens depending on the 
size of the meal. Furthermore, the optimal regimens for high-fat pasta meals are multiphasic 
where the number of waves increases with meal size. These optimized regimens demonstrated 
better performance in in silico trials than any pre-existing regimens currently offered by CSII 
therapy, and could therefore potentially be implemented as general recommendations for similar 
meals.  Table 5 presents a summary of novel open-loop regimens for the 100 g meal scenarios, 
corresponding to the optimization results shown in Figs. 12, 18, and 24. The designs in Table 5 
are expressed in terms of the starting time and duration of each square wave in the regimens as 
well as the percentage of the full insulin dose delivered. This percentage corresponds to the 
fraction of the full insulin dose, as calculated by the subject’s ICR and the carbohydrate content 
in the meal. A library of the novel open-loop regimens for meals comprising 50 and 75 g of 
carbohydrates can be found in Appendix B.  
 
 
Table 5. Novel open-loop regimens for meals comprising 100 g of carbohydrates 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Low-fat High-fat 
Pizza 
High-fat 
Pasta 
     
 
Wave I 
% of Insulin Dose 100 70 45 
Starting time (min) -30 +20 +5 
Duration (min) 15 30 40 
     
Wave II 
% of Insulin Dose - 30 35 
Starting time (min) - +60 +95 
Duration (min) - 25 10 
     
Wave III 
% of Insulin Dose - - 15.5 
Starting time (min) - - +135 
Duration (min) - - 55 
     
Wave IV 
% of Insulin Dose - - 4.5 
Starting time (min) - - +210 
Duration (min) - - 0 
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4.2 Novel Closed-loop Insulin Regimens for Low and High-fat Meals 
In the context of an artificial pancreas with meal announcements, it would be helpful to aid the 
controller with a fixed supplementary insulin regimen that is specific to a particular meal type 
and size. A PID controller was designed to study the two different closed-loop scenarios: simple 
PID control and PID control with a supplementary insulin regimen. The PSO method was used to 
determine the optimal controller parameters for the ten in silico subjects given a standard low-fat 
meal. Optimizations of the supplementary insulin regimens for three meal types of three different 
sizes were then performed with PID control.  
 
Controller Parameter Optimization 
The PSO algorithm was implemented to optimize the PID controller parameters, Kc, τI, and τD, 
for ten adult in silico subjects. The optimization was performed under the condition of a noisy 
subcutaneous sensor to obtain a more robust controller. The controller was tuned to a standard 
low-fat meal comprising 50 g of carbohydrates. The optimized parameters are presented in  
Table 6.  
 
Table 6. Optimized controller parameters for a standard  
              low-fat meal comprising 50 g of carbohydrates 
Controller Parameter Optimized Parameter 
Value 
Kc [mg/dl] -0.46 
τI  [s] 531.8 
τD [s] 333.6 
 
The performance of the designed PID controller using a noisy sensor is evaluated in Fig. 30.  
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         The optimized PID controller performs well for high-fat meals with noisy measurements as 
shown in Fig. 30. However, it is not aggressive enough to avoid hyperglycemia for a low-fat 
meal due to the risk of hypoglycemia. The results suggest that controllers can provide better 
control of the postprandial glucose excursion following high-fat meals due to the slower rise and 
fall in glucose concentration, as long as the integral component is restricted. The given PID 
controller was used to evaluate the improvement in blood glucose control when combined with 
supplementary optimized insulin regimens for a variety of meals. This closed-loop strategy is 
illustrated in Fig. 31.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. PID controller performance with noisy measurements for a low-fat, high-fat pizza, and high-fat pasta meal, each  
                  comprising 50 g of carbohydrates 
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Figure 31. Illustration of closed-loop strategy with controller action  
                combined with a supplementary optimized regimen,  
                specific to a particular meal scenario. 
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         The proposed closed-loop strategy is represented by a combination of PID control and a 
fixed insulin regimen that is optimized for a particular meal type and size, as shown in Fig. 31.  
 
Closed-loop Regimens for Low-fat Meals 
General closed-loop regimens comprising an optimized PID controller in combination with 
supplementary fixed regimens were optimized for ten in silico subjects using PSO. The meal 
scenarios studied were low-fat meals containing 50, 75, and 100 g of carbohydrates. The results 
for 50 and 75 g meals are presented in Appendix B, while the result for a 100 g low-fat meal is 
shown in Fig. 32.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         The results presented in Fig. 32 suggest a supplementary regimen comprising a long square 
wave starting 30 minutes prior to the meal. However, this recommendation was obtained because 
the insulin delivery was constrained to 30 minutes before the meal. It is also important to note 
that the poor performance of the overall regimen is the result of a tuning issue and is not due to 
the meal type. This indicates that the controller tuning needs to be less aggressive for larger 
meals, and particularly fast absorbing meals, such as low-fat meals. The long square wave 
delivery is suggested as the optimal supplementary regimen to avoid postprandial hypoglycemia 
because the given controller is too aggressive for this particular meal. The results are clearly not 
optimal for this type of meal, and due to the poor performance, the results from this optimization 
were not analyzed further. 
Figure 32. Generalized optimal closed-loop insulin regimen for a standard low-fat meal  
                  comprising 100 g of carbohydrates. The upper plot shows the postprandial 
                  blood glucose profiles for ten in silico subjects, and the bottom plot presents 
                  the insulin deliver pattern for all ten subjects.  
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Closed-loop Regimens for High-fat Pizza Meals 
Next, optimized general regimens for high-fat pizza meals of various sizes were found using 
PSO. The optimization result for a pizza meal comprising 100 g of carbohydrates is presented in 
Fig. 33, and the results for 50 and 75 g meals in Appendix B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         The optimization results shown in Fig. 33 propose a closed-loop scheme comprising a 
supplementary biphasic regimen that maintains the blood glucose concentration within the  
70-180 mg/dl safe zone for all subjects. The general regimens for 50 and 75 g pizza meals are 
similarly biphasic, but comprise a short square wave followed by a longer one. The biphasic 
patterns for all three meal sizes conform to the optimal open-loop schemes for this meal type in 
terms of the two hour postprandial insulin infusion, with minor regimen design variations. While 
the open-loop regimen for a 50 g meal comprises a long square wave, the closed-loop scheme is 
biphasic. This difference is possibly a result of limited initial control action due to the slow 
glucose excursion (see Fig. 19). The restricted control action imposes the need for fast insulin 
infusion, explaining the initial short wave in the closed-loop regimen for a 50 g pizza meal. The 
variations in regimen design for a 100 g pizza meal can be explained by the simulated glucose 
absorption profiles in Fig. 19 that show a faster rise in glucose concentration for larger meals. 
This rapid postprandial glucose excursion leads to higher initial derivative control action, which 
explains why the closed-loop insulin regimen for a 100 g pizza meal is initialized by slower 
Figure 33. Generalized optimal closed-loop regimen for a high-fat pizza meal comprising  
                  100 g of carbohydrates. The upper plot shows the postprandial blood glucose  
                  response profiles for ten in silico subjects, and the bottom plot presents the  
                  optimal insulin delivery pattern for all ten subjects. The delivery regimen  
                  maintains a majority of the subjects in euglycemia throughout the trial despite 
                  the high carbohydrate content. 
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insulin infusion than the smaller meals. 
        To confirm the obtained results, the performance of the optimal closed-loop regimen was 
compared to that of simple PID control, the optimal open-loop regimen, and PID control with a 
supplementary 2 hour square wave regimen, as shown in Fig. 34.   
 
 
 
 
 
 
 
 
 
 
 
 
 
         The results in Fig. 34 show that the closed-loop regimens provide significantly better 
control of the postprandial glucose excursion compared to simple PID control and the open-loop 
scheme. However, the performances of the two closed-loop regimens are nearly 
indistinguishable. Table 7 gives a clearer comparison of the different regimens in terms of the 
normalized AUC, average time in the safe zones, and the postprandial blood glucose peak.  
 
 
 
 
 
 
Figure 34. Comparison of insulin regimens for a high-fat pizza meal comprising  
                  100 g of carbohydrates. The solid curves represent the average blood glucose 
                  profiles for ten in silico subjects. The area between the dashed lines shows 
                  the range of variability.                   
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Table 7. Comparison of various insulin regimens for a 100 g carbohydrate pizza meal 
Insulin 
Regimen 
Normalized 
AUC (mg/dl) 
Mean % Time 
within  
70-180 mg/dl 
Mean % Time 
within  
80-140 mg/dl 
Mean Blood Glucose 
Peak (mg/dl) 
Optimal 
Closed-loop 7.2 ± 1.7 100 95.0 ± 3.3 149.9 ± 13.1 
Optimal Open-
loop 8.5 ± 2.2 99.8 ± 0.7 91.7 ± 4.2 157.8 ± 15.6 
Closed-loop 
2 Hour Square 
Wave 
7.9 ± 1.7 99.8 ± 0.5 92.5 ± 4.5 152.4 ± 13.3 
PID Control 23.2 ± 5.9 89.6 ± 3.1 79.6 ± 6.4 229.7 ± 24.4 
 
         From the data presented in Table 7, it is apparent that the optimal closed-loop regimen 
performs better than other regimens since it results in a lower average normalized AUC, blood 
glucose peak and most importantly, no hyperglycemic events. This was also confirmed by 
statistical paired t-tests with an α-level of 0.05. Closed-loop control in combination with a 
supplementary square wave regimen seems to perform relatively well, but statistical tests show 
that the optimal closed-loop regimen is significantly better at controlling the postprandial blood 
glucose excursion indicated by the postprandial peak, time in euglycemia, and AUC. The 
promising results of the novel closed-loop strategy indicate that combining a controller with a 
supplementary optimized regimen can provide efficient control of postprandial blood glucose 
concentration following large meals.  
         The overall results suggest that the optimal closed-loop regimens for high-fat pizza meals 
are biphasic with the insulin dose delivered within a 2 hour postprandial period, independent of 
meal size.   
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Closed-loop Regimens for High-fat Pasta Meals 
Finally, the PSO algorithm was also used to find the optimal closed-loop regimens for various 
high-fat pasta meals. The optimization results for meals comprising 50 and 75 g of carbohydrates 
are presented in Appendix B, and the result for a 100 g meal is shown in Fig. 35.   
 
 
 
 
 
 
 
 
 
 
 
 
         The optimal supplementary closed-loop regimen for a large high-fat pasta meal has a 
biphasic delivery pattern, as shown in Fig. 35. This closed-loop strategy maintains the blood 
glucose concentrations of all subjects within the safe zone of 70-180 mg/dl despite the high 
carbohydrate content. Interestingly, the optimal regimens for 50 and 75 g meals are triphasic, but 
are also extended over a 4 hour postprandial period. Meals comprising a larger amount of 
carbohydrates cause a faster rise in blood glucose, resulting in higher derivative action. This 
explains the extended biphasic pattern that is shown in Fig. 35, since increased control action 
reduces the need for frequent insulin waves. The closed-loop insulin delivery patterns for the 
smaller meal sizes are similar to the optimal open-loop regimens. However, the closed-loop 
design for the meal comprising 100 g of carbohydrates differs from the multiphasic open-loop 
regimen, and is possibly also a result of the significantly higher derivative action that can be 
observed for larger meals.  
         The performance of the optimized regimen was compared to that of simple PID control, the 
optimal open-loop regimen, and PID control with a supplementary 4 hour square wave, as shown 
in Fig. 36.  
Figure 35. Generalized optimal closed-loop regimen for a high-fat pasta meal comprising  
                 100 g of carbohydrates. The upper plot shows the postprandial blood glucose  
                 response profiles for ten in silico subjects, and the bottom plot presents the  
                 optimal insulin delivery pattern for all ten subjects. The delivery regimen  
                 maintains a majority of the subjects in euglycemia throughout the trial. 
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         The results in Fig. 36 suggest that the optimal closed-loop regimen performs better than 
other regimens since it maintains near-euglycemia for all subjects. Although the closed-loop 
scheme with a 4 hour square wave performs comparatively well, the upper glucose range for the 
regimen is well above 140 mg/dl for an extended time period and appears to result in larger 
deviations from the baseline of 110 mg/dl. Table 8 compares these regimens based on the 
average normalized AUC, the postprandial peak, and other performance metrics.   
  
Figure 36. Comparison of insulin regimens for a high-fat pasta meal comprising  
                  100 g of carbohydrates. The solid curves represent the average blood glucose 
                  profiles for ten in silico subjects. The area between the dashed lines shows 
                  the range of variability.                   
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Table 8. Comparison of various insulin regimens for a 100 g carbohydrate pasta meal 
Insulin 
Regimen 
Normalized 
AUC (mg/dl) 
Mean % Time 
within  
70-180 mg/dl 
Mean % Time 
within  
80-140 mg/dl 
Mean Blood Glucose 
Peak (mg/dl) 
Optimal 
Closed-loop 6.8 ± 1.7 100 96.3 ± 5.3 144.8 ± 8.3 
Optimal 
Open-loop 8.3 ± 4.0 99.4 ± 1.9 91.6 ± 6.2 159.3 ± 15.1 
Closed-loop 
4 Hour Square 
Wave 
7.4 ± 1.5 100 96.7 ± 5.2 143.0 ± 9.4 
PID Control 23.0 ± 5.9 89.9 ± 5.8 76.2 ± 5.4 199.7 ± 22.9 
 
         The results shown in Table 8 indicate that closed-loop regimens with supplementary 
optimized regimens are more efficient in controlling postprandial blood glucose concentration 
than open-loop regimens, which was also confirmed by a statistical paired-test. The two closed-
loop strategies with supplementary regimens perform similarly well, as they result in similar 
average blood glucose peaks and percentage of time in the safe zones. However, the optimized 
regimen produces a significantly lower AUC, implying overall less deviation from the baseline. 
Statistical tests confirm that the optimal closed-loop regimen performs significantly better than 
the closed-loop regimen involving a 4 hour square wave in terms of the AUC. The data thus 
suggests that a closed-loop strategy with an optimized supplementary regimen is an effective 
method of controlling the postprandial blood glucose excursion following a large meal.  
         The optimization results propose triphasic closed-loop regimens for small to medium sized 
high-fat pasta meals, and biphasic delivery patterns for large meals. All the novel regimens for 
this type of meal are characterized by insulin deliveries over a 4 hour postprandial period.  
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Summary of Novel Closed-loop Regimens 
The optimizations of closed-loop insulin delivery regimens for various meal types produced 
novel supplementary regimens that can assist controllers in providing efficient control of 
postprandial blood glucose excursions following large meals. The optimal insulin delivery 
regimens for low-fat meals comprise a normal bolus or a short square wave depending on the 
size of the meal. Due to a controller tuning issue, the optimal regimen for large low-fat meals 
could not be determined. While the optimal closed-loop schemes for pizza meals seem to follow 
a biphasic pattern, the regimens for high-fat pasta meals are either bi- or triphasic depending on 
the meal size. The performances of these optimized schemes were superior to closed-loop control 
combined with supplementary existing regimens, such as square waves. This suggests that 
closed-loop PID control in combination with an optimized supplementary insulin delivery 
regimen is an efficient compensation strategy for large meals. As this type of scheme does not 
rely on optimized basal rates, it is a realistic approach that could potentially have real-life 
applications in an artificial pancreas. Table 9 shows a summary of novel closed-loop regimens 
for the 100 g meal scenarios, while a library of schemes for 50 and 75 g meals can be found in 
Appendix B.  
 
Table 9. Novel supplementary regimens in a closed-loop setting 
              for meals comprising 100 g of carbohydrates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  High-fat 
Pizza 
High-fat 
Pasta 
    
 
Wave I 
% of Insulin Dose 51 64 
Starting time (min) -20 +30 
Duration (min) 80 25 
    
Wave II 
% of Insulin Dose 48 36 
Starting time (min) +80 +170 
Duration (min) 20 40 
    
Wave III 
% of Insulin Dose - - 
Starting time (min) - - 
Duration (min) - - 
    
Wave IV 
% of Insulin Dose - - 
Starting time (min) - - 
Duration (min) - - 
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5. Robustness Analysis 
Both closed-loop and conventional CSII with user announcements require a number of parameter 
estimates, including meal size and ICR.  This gives rise to uncertainties in the insulin dose and 
could potentially cause postprandial hyper- or hypoglycemia due to over- or under-delivery of 
insulin. Therefore, it is important that the insulin delivery regimen is robust to uncertainties in 
various factors. The robustness of each novel regimen was evaluated in terms of its sensitivity to 
errors in meal and ICR estimates. 
 
 
5.1 Regimens for Low-fat Meals 
A robustness analysis was performed for three different regimens for a low-fat meal comprising 
100 g of carbohydrates. In Table 6, two novel regimens are compared to a normal bolus 
delivered 30 minutes prior to the meal as this pre-existing regimen showed similar performance 
to the novel open-loop regimen (see Chap. 4.1 Novel Open-loop Insulin Regimens for Low- and 
High-fat Meals).  
 
Table 6. Robustness analysis results for a normal bolus and two novel insulin regimens given a  
              low-fat meal comprising 100 g of carbohydrates. 
Regimens  Meal Size Estimate I:C Ratio estimate 
  -25% Nominal +25% -25% Nominal +25% 
Normal Bolus 
30 minutes 
Prior to Meal 
% Time in Hyperglycemia 8.2±3.9 2.4±2.7 0 6.4±4.5 2.4±2.7 0.2±0.6 
% Time in Hypoglycemia 0.03±0.1 0.03±0.1 0.05±0.2 0 0.03±0.1 0.08±0.3 
Blood Glucose Peak (mg/dl) 224±24.3 185±14.7 155±10.3 208±21.9 185±14.7 168±12.8 
Normalized AUC (mg/dl) 15.4±6.3 9.8±2.2 7.8±2.3 13.9±6.3 9.8±2.2 9.8±3.0 
        
Optimal 
Open-loop  
% Time in Hyperglycemia 7.2±3.1 2.4±2.5 0 5.9±4.0 2.4±2.5 0.2±0.6 
% Time in Hypoglycemia 0 0 0 0 0 2.2±3.8 
Blood Glucose Peak (mg/dl) 225±21.9 187±13.9 158±10.3 208±20.2 187±13.9 172±12.7 
Normalized AUC (mg/dl) 14.3±4.5 9.9±2.1 8.8±2.7 13.0±5.0 9.9±2.1 11.2±3.6 
        
Optimal 
Closed-loop  
% Time in Hyperglycemia 4.8±1.3 2.8±1.3 0.4±0.7 4.0±1.4 2.8±1.3 1.6±1.1 
% Time in Hypoglycemia 0.4±1.3 0.3±1.0 0.2±0.7 0 0.3±1.0 0.5±1.6 
Blood Glucose Peak (mg/dl) 236±19.3 202±14.0 175±10.8 216±16.5 202±14.0 191±13.1 
Normalized AUC (mg/dl) 11.7±2.3 8.0±1.2 6.6±1.3 10.1±1.9 8.0±1.2 7.8±1.6 
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         The results in Table 6 show that the novel open-loop regimen has comparable robustness to 
the existing regimen. Interestingly, the novel regimen appears to be more robust to errors in the 
meal size estimate than the normal bolus delivered 30 minutes prior to the meal as it results in 
less hyper- and hypoglycemic events. Statistical paired t-tests with an α-level of 0.05 also show 
that the novel open-loop regimen is generally significantly more robust than the normal bolus. 
Overall, for large fast absorbing meals, the closed-loop performs worse than the open-loop 
regimens due to a controller tuning issue. However, the low standard deviation and small 
variations in performance across the different scenarios suggest that a correctly tuned controller 
in combination with an optimized supplementary regimen will be more robust to uncertainties in 
the meal size and ICR compared to open-loop therapy.   
 
5.2 Regimens for High-fat Pizza Meals 
Next, three insulin regimens for a high-fat pizza meal were evaluated in terms of their robustness 
to errors in meal size and ICR estimates. The results from the analysis are presented in Table 7, 
which compares the performance of two novel regimens and a 2 hour square wave.  
 
Table 7. Robustness analysis results for a 2 hour square wave and two novel insulin regimens  
              given a high-fat pizza meal comprising 100 g of carbohydrates. 
Regimens  Meal Size Estimate I:C Ratio estimate 
  -25% Nominal +25% -25% Nominal +25% 
 
2 Hour 
Square Wave 
 
% Time in Hyperglycemia 6.4±5.2 0.4±0.8 0 4.1±4.9 0.4±0.8 0 
% Time in Hypoglycemia 0 0 0 0 0 0 
Blood Glucose Peak (mg/dl) 197±26.3 161±15.7 135±8.9 188±24.3 161±15.7 142±11.1 
Normalized AUC (mg/dl) 15.5±6.3 9.3±2.1 6.4±1.8 14.2±6.4 9.3±2.1 8.0±2.2 
        
Optimal 
Open-loop  
% Time in Hyperglycemia 4.8±4.7 0.2±0.7 0 2.9±4.6 0.2±0.7 0 
% Time in Hypoglycemia 0 0 0 0 0 0 
Blood Glucose Peak (mg/dl) 193±25.8 158±15.6 131±8.1 183±23.3 158±15.6 138±11.0 
Normalized AUC (mg/dl) 14.7±6.3 8.5±2.2 5.6±1.7 13.4±6.2 8.5±2.2 7.0±2.2 
        
Optimal 
Closed-loop  
% Time in Hyperglycemia 0.8±2.0 0.08±0.3 0 0.4±1.4 0.08±0.3 0 
% Time in Hypoglycemia 0 0 0 0 0 0 
Blood Glucose Peak (mg/dl) 173±17.7 150±13.2 132±9.2 165±15.5 150±13.2 138±10.9 
Normalized AUC (mg/dl) 11.3±2.5 7.2±1.7 4.8±1.6 10.0±2.4 7.2±1.7 5.5±1.4 
 
        Table 7 shows that the optimal open-loop regimen is more robust to uncertainties in meal 
size and ICR compared to a 2 hour square wave. A statistical paired t-test with an α-level of 0.05 
also confirmed that the novel open-loop regimen is significantly more robust. The novel regimen 
results in fewer hyperglycemic events and maintains comparatively lower blood glucose peaks 
and normalized AUC for the different scenarios. The overall better performance of the general 
optimal regimen suggests that it could provide better control of postprandial glucose 
concentration for large pizza meals compared to pre-existing delivery patterns.  The optimized 
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closed-loop scheme performs better than the two open-loop regimens for the nominal case since 
it results in considerably lower AUC, blood glucose peaks, and fewer hyperglycemic events. 
Statistical tests also show that the novel closed-loop regimen is significantly more robust to 
errors in meal size and ICR estimates compared to the open-loop schemes. The closed-loop 
strategy also displays significantly lower standard deviations for all measured parameters, 
indicating that the regimen is robust to inter-subject variability.  
 
 
5.3 Regimens for High-fat Pasta Meals 
Finally, the robustness of a 4 hour square wave and two novel regimens was evaluated in terms 
of their sensitivity to perturbations in meal size and ICR estimates for high-fat pasta meals. Table 
8 compares the performance of these three regimens for various scenarios.  
 
Table 8. Robustness analysis results for a 4 hour square wave and two novel insulin regimens  
              given a high-fat pasta meal comprising 100 g of carbohydrates.  
Regimens  Meal Size Estimate I:C Ratio estimate 
  -25% Nominal +25% -25% Nominal +25% 
 
4 Hour 
Square Wave 
 
% Time in Hyperglycemia 4.4±7.0 0 0 3.5±6.1 0 0 
% Time in Hypoglycemia 0 0 0 0 0 0 
Blood Glucose Peak (mg/dl) 185±22.3 153±12.5 132±7.8 177±21.2 153±12.5 138±9.4 
Normalized AUC (mg/dl) 16.2±7.0 9.6±2.9 6.2±2.4 14.8±6.9 9.6±2.9 7.6±3.0 
        
Optimal 
Open-loop 
Regimen 
% Time in Hyperglycemia 4.3±6.5 0.6±1.9 0 3.0±5.5 0.6±1.9 0 
% Time in Hypoglycemia 0 0 0 0 0 1.6±2.7 
Blood Glucose Peak (mg/dl) 192±24.9 159±15.1 127±9.3 181±21.8 159±15.1 136±10.5 
Normalized AUC (mg/dl) 15.5±8.7 8.2±4.1 6.7±3.2 14.0±7.6 8.2±4.1 7.5±3.1 
        
Optimal 
Closed-loop 
Regimen 
% Time in Hyperglycemia 0.1±0.4 0 0 0 0 0 
% Time in Hypoglycemia 0 0 0 0 0 0 
Blood Glucose Peak (mg/dl) 163±11.7 145±8.3 130±5.4 156±10.5 145±8.3 134±6.4 
Normalized AUC (mg/dl) 10.9±2.5 6.8±1.7 4.8±1.6 9.8±2.4 6.8±1.7 5.3±1.6 
 
         The results from the analysis show that the novel open-loop scheme is similarly robust to 
errors in meal size and ICR estimates as the 4 hour square wave and was also confirmed by 
statistical tests. The performances of both regimens across the various scenarios are comparable 
in terms of the average time in hyperglycemia, but the novel regimen results in overall lower 
AUCs. The novel closed-loop regimen provides significantly better postprandial glucose control 
since it maintains lower blood glucose peaks and results in a negligible number of hyperglycemic 
events. The AUC and standard deviations are also considerably low for this regimen, indicating 
that it is a generally more robust method. Statistical tests also show that the closed-loop regimen 
is a comparatively more robust to errors in meal size and ICR estimates.  
         The overall results from the robustness analysis of insulin regimens for all three meal types 
show that the novel open-loop schemes are more or similarly robust to uncertainties in meal size 
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and ICR estimates as existing schemes. The data also indicates that closed-loop regimens 
comprising a PID controller in combination with a supplementary optimized regimen are more 
robust since the variation in performance over the different scenarios is relatively small. This 
type of scheme does not rely on optimal basal therapy and is thus a more realistic strategy that 
could potentially have real-life applications in an artificial pancreas. 
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6. Discussion 
The insulin delivery profile for a standard meal in conventional basal-bolus therapy comprises a 
normal bolus (Jones et al., 2005).  The performances of the novel open- and closed-loop insulin 
regimens were therefore compared to this bolus type (see Appendix B). The comparison made 
in Fig. B3 shows that the novel regimens perform significantly better than the normal bolus for 
all 9 meal scenarios with lower postprandial peaks, longer time spent in euglycemia, and less 
deviations from the baseline concentration of 110 mg/dl. In simulation trials, the normal bolus 
demonstrates adequate performance for fast absorbing low-fat meals, but does not appear to be 
the optimal compensation method for slow absorbing high-fat meals. This confirms recently 
published clinical data by Chase et al. (2002) and Jones et al. (2005). These studies suggest that 
insulin delivered as a dual wave is the optimal scheme for high-fat meals. However, this finding 
is based on performance comparisons of a limited number of schemes. The other types of 
insulin regimens that have been considered for such meals are the traditional normal bolus and 
square wave bolus, but they have not been as successful at attenuating the postprandial blood 
glucose peak as the dual wave (Chase et al., 2002). Since other types of delivery profiles have 
not yet been explored, it has not been possible to verify that the dual wave is in fact the optimal 
regimen for high-fat meals. 
         The results obtained in this simulation study indicate that regimens with slower insulin 
infusion rates provide better attenuation of the postprandial glucose excursions following high-
fat meals. This confirms previous findings by Jones et. al (2005) and Chase et al.(2002). 
However, the novel regimen designs differ from traditional bolusing schemes as they comprise 
unique waveforms that are either bi- or multiphasic. Although the dual wave bolus is currently 
considered the optimal regimen for high-fat meals, the novel open- and closed-loop regimens 
generated in this study show superior postprandial control in in silico trials. Furthermore, these 
trials proved them to be more or similarly robust to uncertainties in meal size and ICR estimates 
as existing schemes.  
         Although the novel regimens show promising results in controlling postprandial blood 
glucose concentrations, the optimization problem framework could be improved to allow other 
types of delivery patterns that are not restricted to a multiple wave pattern. However, this would 
result in a large number of variables and extremely long computation time.  Consequently, an 
alternative optimization approach would be necessary to produce more flexible insulin delivery 
designs. The insulin regimen library constructed in this study could also be extended with access 
to more clinical data on the postprandial glucose responses to high-fat meals in people with type 
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1 diabetes. Through in silico replication of additional data, it would be possible to find optimal 
insulin delivery patterns for a larger variety of meal compositions. Additionally, although the in 
silico trials were successful, an even more interesting evaluation of the novel insulin regimens 
would be that of a clinical trial. This would be necessary to confirm the in silico results and is 
required before considering practical applications of the novel regimens proposed in this study.  
For long term goals, other hormones that influence meal absorption can also be utilized to 
improve overall meal compensation. Pramlintide is an analogue of the hormone amylin that 
decreases the meal absorption rate, and an optimized insulin and pramlintide delivery model that 
takes into account administration of both hormones may be the key in further improving 
postprandial blood glucose control. Ultimately, the optimization approach developed for the 
duration of this project is robust and widely applicable to other areas of the artificial pancreas, 
and has laid the groundwork for efforts that incorporate similar approaches in controller and 
model parameter estimations.  
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7. Conclusions  
A model of the glucose-insulin dynamics in a person with type 1 diabetes mellitus currently 
implemented in the FDA-accepted UVA/Padova metabolic simulator was modified to allow 
simulation of meals of different absorption rates. This modification was utilized for extensive 
evaluation of multiple novel insulin regimens under meals with varied fat content. Simulations of 
high-fat meals under this modified model demonstrated qualitative replications of published data. 
Subsequently, an insulin regimen library with novel meal compensation strategies for a variety of 
meal compositions was constructed using the particle swarm optimization methodology.  
        Solving these optimization problems yielded novel open- and closed-loop regimens that 
provide better control of the postprandial glucose excursions than existing schemes. These novel 
delivery patterns comprise unique waveforms that are not available in existing insulin pump 
wizards as they have very limited bolus options, mainly normal bolus, dual wave, and square 
wave. The optimization results show that the theoretically optimal open-loop insulin delivery 
regimens for low-fat meals comprise a normal bolus or a short square wave delivered at least 30 
minutes prior to the meal. However, it is important to consider the risks associated with early 
insulin deliveries. Optimal regimens for high-fat meals are typically biphasic, but can extend to 
multiple phases depending on the meal absorption rate and carbohydrate content. Individually 
tailored optimizations demonstrate a clear trend for subjects with high insulin sensitivity, 
suggesting that these patients should follow a biphasic insulin delivery for high-fat meals. 
Preliminary investigations of the optimal closed-loop regimens under varied fat content also 
display bi- or triphasic patterns for high-fat meals and are primarily influenced by the 
carbohydrate content in the meal.  
        The robustness analysis of the novel strategies revealed that the open-loop regimens are 
more or similarly robust to uncertainties in meal size and ICR estimates as existing schemes. 
However, novel closed-loop designs with supplementary optimized regimens are significantly 
more robust as determined by minimal inter-subject variability as well as improved overall 
control performance. Since this scheme does not rely on individually optimized basal rates, it is a 
more realistic strategy that could have real-life applications in an artificial pancreas.  
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Appendix A  
 
Computational Parameters in the Insulin Regimen Optimization  
This chapter serves to further explain the insulin regimen optimization and design for each meal 
scenario.  
 
The insulin regimen was designed as a multiple delivery scheme with four possible doses. The 
optimization variables are the time of each insulin delivery, the duration of each delivery, and the 
fraction of the full insulin dose to be administered with each delivery. The lower and upper limits 
for each variable are given in Table A1. 
 
 
Table A1. Lower and upper limits for the optimization variables 
 
 
 
 
 
 
 
 
 
In addition to the specified limits, the insulin dosage was restricted to the calculated full insulin 
dose as determined by Eq. 1. The dosage constraint is presented in Eq. A1. 
 
෍୧ ൑ ͳ
୬ୀସ
୧
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, where i denotes a specific dose in the optimized multiple delivery regimen and xi is the fraction 
of the full insulin dose administered with the ith delivery.  
 
The various insulin regimens were optimized based on the cost function in Eq. A2.  
 
 Lower Limit  Upper Limit 
Time of Delivery        (min)             - 30 + 300 
Duration of Delivery (min)     0 + 150 
Fraction of Full Dose     0         1 
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, where the percentage of time in hypo- and euglycemia was calculated as an average for ten in 
silico subjects. The last term in Eq. A2 represents the residual sum of squares where i denotes a 
specific data point in a system with a discrete time step of five minutes, and the variable BGi is 
the ith recorded average blood glucose concentration in simulation. The cost function was 
designed to maximize the time spent in euglycemia, minimize the time in hypoglycemia, and 
reduce the deviation from the baseline of 110 mg/dl.  
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Appendix B  
 
Novel Insulin Regimens 
This chapter presents the novel open- and closed-loop insulin regimens that were obtained 
through optimization using the Particle Swarm Optimization algorithm.  
 
The novel regimens for three different meal types are presented in Figs. B1 and B2. Fig. B1 
shows the open-loop regimens for 9 meal scenarios, and the closed-loop regimens for the same 
scenarios are shown in Fig. B2. Fig. B3 demonstrates a performance comparison between the 
novel regimens and the conventional insulin delivery profile for a standard meal.  
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